Attenuated Vancomycin Bactericidal Activity against Staphylococcus aureus hemB Mutants Expressing the Small-Colony-Variant Phenotype
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The in vitro bactericidal activities of vancomycin against Staphylococcus aureus hemB mutants displaying the small-colony-variant phenotype and their parental strains were evaluated. Vancomycin killing activities against hemB mutants were markedly attenuated, demonstrating approximately 50% less effect, a result which was well described by a Hill-type pharmacodynamic model.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to aminoglycoside resistance, SCVs that arise via the loss of the electron transport chain are more tolerant than wild-type bacteria of other classes of bactericidal antibiotics (8, 9, 25–29).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [29]
Citations
Cites
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
Sakoulas, G., Moise-Broder, P. A., Schentag, J., Forrest, A., Moellering, R. C., & Eliopoulos, G. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2398-2402.2004 · Cited by 836 · cited 1×
“Slow clinical responses, vancomycin’s slow bactericidal or bacteriostatic killing activity, and strains which display heterogeneous resistance to vancomycin severely limit its use for persistent infections (6, 9, 15).”
BackgroundSelf-citationVancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance
Hiramatsu, K. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00091-3 · Cited by 759
Levine, D. P., Fromm, B. S., & Reddy, B. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-674 · Cited by 577 · cited 1×
“Slow clinical responses, vancomycin’s slow bactericidal or bacteriostatic killing activity, and strains which display heterogeneous resistance to vancomycin severely limit its use for persistent infections (6, 9, 15).”
BackgroundKahl, B., Herrmann, M., Everding, A. S., Koch, H. G., Becker, K., Harms, E., Proctor, R. A., & Peters, G. (1998) · Journal of Infectious Diseases · doi:10.1086/515238 · Cited by 357 · cited 1×
“These fastidious variants characterized by decreased pigment formation, reduced hemolytic activity, and decreased coagulase activity have been associated with chronic, relapsing, and persistent infections (8, 17, 18).”
Backgroundvon Eiff, C., Heilmann, C., Proctor, R. A., Woltz, C., Peters, G., & Götz, F. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.15.4706-4712.1997 · Cited by 310 · cited 1×
“aureus SCVs may lie in their ability to persist intracellularly in nonprofessional phagocytes, thus evading surrounding host defenses and antimicrobial agents (4, 11, 23, 26).”
Backgroundvon Eiff, C., Bettin, D., Proctor, R. A., Rolauffs, B., Lindner, N., Winkelmann, W., & Peters, G. (1997) · Clinical Infectious Diseases · doi:10.1086/516962 · Cited by 247
Influence of a Functional sigB Operon on the Global Regulators sar and agr in Staphylococcus aureus
Bischoff, M., Entenza, J. M., & Giachino, P. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.17.5171-5179.2001 · Cited by 235 · cited 1×
“Interestingly, it has been demonstrated previously that B reduces the levels of RNA III, the effector molecule of the agr system, in a growth phase-dependent manner (3, 20).”
BackgroundStaphylococcal Small Colony Variants Have Novel Mechanisms for Antibiotic Resistance
Proctor, R. A., Kahl, B., von Eiff, C., Vaudaux, P. E., Lew, D. P., & Peters, G. (1998) · Clinical Infectious Diseases · doi:10.1086/514906 · Cited by 204 · cited 2×
“aureus SCVs may lie in their ability to persist intracellularly in nonprofessional phagocytes, thus evading surrounding host defenses and antimicrobial agents (4, 11, 23, 26).”
Background
Research works printed but not linked: 1
- 10.3201/eid0910.0302000 · doi:10.3201/eid0910.0302000 · Paper page
Cited by
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
“The vancomycin killing activity was reduced in the SCV compared to the parental strain (359).”
BackgroundKahl, B. C., Becker, K., & Löffler, B. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00069-15 · Cited by 325
“activities compared to those for the parental isolates (195).”
BackgroundGao, W., Chua, K., Davies, J. K., Newton, H. J., Seemann, T., Harrison, P. F., Holmes, N. E., Rhee, H.-W., Hong, J.-I., Hartland, E. L., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000944 · Cited by 218
“[12], and reduced virulence [13].”
Garcia, L. G., Lemaire, S., Kahl, B. C., Becker, K., Proctor, R. A., Denis, O., Tulkens, P. M., & Van Bambeke, F. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt072 · Cited by 177
Painter, K. L., Strange, E., Parkhill, J., Bamford, K. B., Armstrong-James, D., & Edwards, A. M. (2015) · Infection and Immunity · doi:10.1128/iai.03016-14 · Cited by 153
Bulitta, J. B., Yang, J. C., Yohonn, L., Ly, N. S., Brown, S. V., D'Hondt, R. E., Jusko, W. J., Forrest, A., & Tsuji, B. T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00881-09 · Cited by 152
“Colony counts were determined as previously described (68)”
MethodSelf-citationOrazi, G., Ruoff, K. L., & O’Toole, G. A. (2019) · mBio · doi:10.1128/mbio.01501-19 · Cited by 123
“aureus small colony variants (SCVs) both exhibit high tolerance to many classes of 141 antibiotics (57-59), likely because the bacteria need to be actively growing in order for many 142 antibacterial compounds to be effective.”
BackgroundJohns, B. E., Purdy, K. J., Tucker, N. P., & Maddocks, S. (2015) · Microbiology Insights · doi:10.4137/mbi.s25800 · Cited by 111
Bulitta, J. B., Ly, N. S., Yang, J. C., Forrest, A., Jusko, W. J., & Tsuji, B. T. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00489-08 · Cited by 98
“formed at CFUo of 10(6), 10(7), and 10(8) CFU/ml using a previously described methodology (65).”
MethodSelf-citationLenhard, J. R., Smith, N. M., Bulman, Z. P., Tao, X., Thamlikitkul, V., Shin, B. S., Nation, R. L., Li, J., Bulitta, J. B., & Tsuji, B. T. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01268-16 · Cited by 88
“baumannii strains (N5406 and 03-149-2) using an established methodology (10) that was adapted to accommodate a high bacterial burden of 108 CFU/ml to approximate the burden involved with a life-threatening A.”
MethodSelf-citationThe Impact of Capsid Proteins on Virus Removal and Inactivation during Water Treatment Processes
Mayer, B. K., Yang, Y., Gerrity, D. W., & Abbaszadegan, M. A. (2015) · Microbiology Insights · doi:10.4137/mbi.s31441 · Cited by 89
Landersdorfer, C. B., Ly, N. S., Xu, H., Tsuji, B. T., & Bulitta, J. B. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00092-13 · Cited by 76
Self-citationVancomycin Heteroresistance and Methicillin-Resistant Staphylococcus aureus
Deresinski, S. (2009) · Journal of Infectious Diseases · doi:10.1086/596630 · Cited by 55
“These include intracellular residence [22], growth as small colony variants [23] and biofilm [24], and tolerance [25].”
BackgroundHarigaya, Y., Bulitta, J. B., Forrest, A., Sakoulas, G., Lesse, A. J., Mylotte, J. M., & Tsuji, B. T. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01585-08 · Cited by 55
“A sigmoidal Hill-type model using an area-based method has been utilized previously in our laboratory and by other groups to characterize the effect of vancomycin killing against MRSA (23, 40).”
MethodSelf-citationTsuji, B. T., Landersdorfer, C. B., Lenhard, J. R., Cheah, S.-E., Thamlikitkul, V., Rao, G. G., Holden, P. N., Forrest, A., Bulitta, J. B., Nation, R. L., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02831-15 · Cited by 51
“An area-based integrated PK/PD measure was utilized as previously described (22).”
MethodSelf-citationZhou, Y., Tao, M.-T., Feng, Y., Yang, R., Liao, X., Liu, Y., & Sun, J. G. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx038 · Cited by 48
Painter, K. L., Hall, A., Ha, K. P., & Edwards, A. M. (2017) · Infection and Immunity · doi:10.1128/iai.00659-17 · Cited by 51
Balato, G., Roscetto, E., Vollaro, A., Galasso, O., Gasparini, G., Ascione, T., Catania, M. R., & Mariconda, M. (2018) · Knee Surgery Sports Traumatology Arthroscopy · doi:10.1007/s00167-018-5230-x · Cited by 41
Butterfield, J. M., Tsuji, B. T., Brown, J. E., Ashley, E. D., Hardy, D. J., Brown, K., Forrest, A., & Lodise, T. P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00407-11 · Cited by 37
Self-citationLy, N. S., Yang, J. C., Bulitta, J. B., & Tsuji, B. T. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06380-11 · Cited by 36
“The log ratio area method was utilized as the pharmacokinetic/pharmacodynamic measurement (29) and fit by a Hill pharmacodynamic model using the linear trapezoidal rule and nonlinear regression using WinNonlin (version 5.”
MethodSelf-citationSavage, V. J., Chopra, I., & O’Neill, A. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062513 · Cited by 39
“It has also been demonstrated that the biofilms of some species contain large subpopulations of small colony variants (SCVs) [10,11]; such variants exhibit reduced susceptibility to a variety of antimicrobial agents [6,12], and may play a key role in establishing chronic infection [13].”
BackgroundGuía de tratamiento de la infección producida por Staphylococcus aureus resistente a meticilina
Pueyo, J. M., Barberán, J., Mondéjar, P. L., Picazo, J. J., Bouza, E., Lerma, F. Á., Floege, J., Serrano, R., Leon, C. A., Guirao, X., et al. (2008) · Revista española de quimioterapia. Suplemento · Cited by 34
Tsuji, B. T., Bulitta, J. B., Brown, T., Forrest, A., Kelchlin, P. A., Holden, P. N., Peloquin, C. A., Skerlos, L. A., & Hanna, D. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks201 · Cited by 34
Self-citationBegic, D., von Eiff, C., & Tsuji, B. T. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp069 · Cited by 33
Self-citationTsuji, B. T., Brown, T., Parasrampuria, R., Brazeau, D. A., Forrest, A., Kelchlin, P. A., Holden, P. N., Peloquin, C. A., Hanna, D. L., & Bulitta, J. B. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05453-11 · Cited by 32
“Using nonlinear regression, a four-parameter concentration-effect Hill-type model was fit to the effect parameter using the software program Systat (version 11; Systat Software, Richmond, VA) using equation 2, as previously described (30):”
MethodSelf-citationBogut, A., & Magryś, A. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04315-1 · Cited by 33
El catéter periférico: el gran olvidado de la infección nosocomial
Capdevila, J. A. (2013) · Revista española de quimioterapia. Suplemento · Cited by 59
Lenhard, J. R., von Eiff, C., Hong, I. S., Holden, P. N., Bear, M. D., Suen, A., Bulman, Z. P., & Tsuji, B. T. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04508-14 · Cited by 31
“Building upon previous studies, we determined that vancomycin activity against cells with the SCV phenotype was diminished relative to that against cells of the NP at a high bacterial density (11).”
MethodResultSelf-citationTsuji, B. T., MacLean, R. D., Dresser, L., Mcgavin, M. J., & Simor, A. E. (2011) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-10-20 · Cited by 25
“Selective time-kill experiments were performed in duplicate for vancomycin against agr functional and dysfunctional CA-MRSA and HA-MRSA using methodology as previous described[13].”
MethodSelf-citationOptimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosa
Ly, N. S., Bulman, Z. P., Bulitta, J. B., Baron, C., Rao, G. G., Holden, P. N., Li, J., Sutton, M. D., & Tsuji, B. T. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02377-15 · Cited by 24
Self-citationLenhard, J. R., Brown, T., Rybak, M. J., Meaney, C. J., Norgard, N. B., Bulman, Z. P., Brazeau, D. A., Gill, S. R., & Tsuji, B. T. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02657-15 · Cited by 25
Self-citationSmall-Colony Variants in Persistent and Recurrent Staphylococcus aureus Bacteremia
Kim, K.-H., Kang, Y. M., Han, W. D., Park, K. U., Park, K., Yoo, J. I., Lee, D., Park, C., Song, K., Kim, E. S., et al. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2015.0262 · Cited by 28
“42 However, its activity against SCVs has been shown to be diminished, 43,44 and therapeutic failures have also been reported.”
Tsuji, B. T., Harigaya, Y., Lesse, A. J., Sakoulas, G., & Mylotte, J. M. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.01.028 · Cited by 23
“Static time kill experiments were performed as described previously (Tsuji et al., 2008).”
MethodSelf-citationBulman, Z. P., Ly, N. S., Lenhard, J. R., Holden, P. N., Bulitta, J. B., & Tsuji, B. T. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00096-16 · Cited by 21
“The log ratio change was calculated to compare killing at individual time points, whereas the log ratio area was used to assess activity throughout the time-kill experiments, as described previously (26).”
MethodSelf-citationWright, J. A., & Nair, S. P. (2012) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2012.02519.x · Cited by 17
“In particular, strains with mutations in the hemB gene, which encodes a 5-aminolevulinic acid dehydratase required for heme biosynthesis, have been extensively characterized (von Eiff et al., 1997a, b; Baumert et al., 2002; Bates et al., 2003; Jonsson et al., 2003; Kohler et al., 2003; Seggewiss et al., 2006; Tsuji et…”
BackgroundLenhard, J. R., Gall, J. S., Bulitta, J. B., Thamlikitkul, V., Landersdorfer, C. B., Forrest, A., Nation, R. L., Li, J., & Tsuji, B. T. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.07.024 · Cited by 17
Self-citationCalycosin enhances the bactericidal efficacy of polymyxin B by inhibiting MCR‐1 in vitro
Liu, X., Sun, X., Deng, X. M., Lv, X., & Wang, J. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14635 · Cited by 17
“The time-killing assay was used to identify the bactericidal effect of polymyxin B alone, calycosin alone or polymyxin B in combination with calycosin (Tsuji et al. 2008).”
MethodSoon, R. L., Lenhard, J. R., Bulman, Z. P., Holden, P. N., Kelchlin, P. A., Steenbergen, J. N., Friedrich, L. V., Forrest, A., & Tsuji, B. T. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02635-15 · Cited by 15
“Time-kill experiments were performed for ceftolozane and tazobactam alone and in combination, using previously described methods (15).”
MethodSelf-citationLiu, J., Shen, Z., Tang, J. L., Huang, Q., Jian, Y., Liu, Y., Wang, Y., Ma, X., Liu, Q., He, L., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02423-4 · Cited by 15
Tsuji, B. T., Harigaya, Y., Lesse, A. J., Forrest, A., & Ngo, D. T. (2013) · Journal of Chemotherapy · doi:10.1179/1973947812y.0000000060 · Cited by 12
Self-citationVaudaux, P. E., Huggler, E., Rhys‐Williams, W., Love, W. G., & Lew, D. P. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.01.015 · Cited by 9
Tsuji, B. T., Fisher, J. R., Boadi-Yeboah, R., Holden, P. N., Sethi, S., Pettigrew, M. M., & Murphy, T. F. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01995-17 · Cited by 8
“An integrated PK/PD approach was utilized, as defined previously (15).”
MethodSelf-citationHuang, V., & Eells, S. J. (2011) · Wiley eBooks · doi:10.1002/9781118063842.ch10 · Cited by 9
Soon, R. L., Lenhard, J. R., Bulman, Z. P., Holden, P. N., Kelchlin, P. A., Steenbergen, J. N., Friedrich, L. V., Forrest, A., & Tsuji, B. T. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.07.015 · Cited by 7
Self-citationEmergence of Polymyxin B Resistance Influences Pathogenicity in Pseudomonas aeruginosa Mutators
Bulman, Z. P., Sutton, M. D., Ly, N. S., Bulitta, J. B., Holden, P. N., Nation, R. L., Li, J., & Tsuji, B. T. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04629-14 · Cited by 7
“ments were performed as previously described (15).”
Self-citationMerali, S. J., Lenhard, J. R., Forrest, A., Holden, P. N., Bulitta, J. B., & Tsuji, B. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156131 · Cited by 7
“To accommodate all available data generated for each concentration tested, and to avoid conclusions based on bacterial counts at a single time point, an integrated pharmacokinetic / pharmacodynamic area measure (log ratio area) was applied to all data as previously described [5].”
InfluentialSelf-citationWu, M., von Eiff, C., Laham, N. A., & Tsuji, B. T. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01597-08 · Cited by 7
“, San Jose, CA) as previously described (12) and equation 3.”
BackgroundMethodInfluentialSelf-citationKaracic, J., Große, M., Pfarr, K. M., Schiefer, A., Schneider, T., Hoerauf, A. M., Karačić, S., Parčina, M., Hischebeth, G. T. R., Fröschen, F. S., et al. (2026) · Infection · doi:10.1007/s15010-026-02760-8 · Cited by 3
Smělíková, E., Krůtová, M., Čapek, V., Brajerova, M., Dřevínek, P., & Tkadlec, J. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117624 · Cited by 2
Place de la daptomycine dans les infections ostéoarticulaires
Carsenti-Dellamonica, H. (2010) · Antibiotiques · doi:10.1016/j.antib.2010.05.001
Metadata
- Authors
- Tsuji, B. T., von Eiff, C., Kelchlin, P. A., Forrest, A., & Smith, P. F.
- Affiliations
- Roswell Park Comprehensive Cancer Center (US)
- Institute of Medical Microbiology, University of Münster, Münster, Germany
- University at Buffalo, State University of New York (US)
- Corresponding author
- Tsuji, Brian T.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2008-04
- Volume
- 52
- Issue
- 4
- Pages
- 1533-1537
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2292514
- OpenAlex
- W2156669393
- Cited by
- 51
- References
- 29
- Citations by year
- 2026: 1 · 2025: 1 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 5 · 2016: 8 · 2015: 5 · 2014: 1 · 2013: 6 · 2012: 4
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- vancomycin, Staphylococcus aureus, bactericidal activity, vancomycin resistance, folate biosynthesis
- MeSH terms
- Anti-Bacterial Agents, Hemin, Humans, Microbial Sensitivity Tests, Mutation, Phenotype, Staphylococcus aureus, Vancomycin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.